UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000062645
Receipt number R000071706
Scientific Title Effects of pre-exercise protein ingestion on performance and executive function
Date of disclosure of the study information 2026/08/21
Last modified on 2026/08/21 11:21:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of pre-exercise protein ingestion on performance and executive function

Acronym

Effects of pre-exercise protein ingestion on performance and executive function

Scientific Title

Effects of pre-exercise protein ingestion on performance and executive function

Scientific Title:Acronym

Effects of pre-exercise protein ingestion on performance and executive function

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to clarify the effects of pre-exercise protein ingestion on performance in resistance and endurance exercise, and on executive function after exercise.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Study 1: total number of repetitions across five sets of leg press performed to volitional failure at 70% of one-repetition maximum. Study 2: time to exhaustion during incremental cycling exercise.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

A single dose of whey protein (SAVAS Aqua Whey Protein 100, Meiji Co., Ltd.) equivalent to 0.4 g of protein per kilogram of body weight (approximately 0.56 g of powder per kilogram, up to a maximum of 56 g of powder per dose), dissolved in 400 mL of water, is ingested 60 minutes before exercise. The exercise task starts 60 minutes after ingestion.

Interventions/Control_2

Only 400 mL of water is ingested 60 minutes before exercise. The same exercise task as in the protein arm starts 60 minutes after ingestion. The two conditions are administered in a randomized crossover order, with an interval of at least one week between conditions.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

30 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy adults affiliated with Niigata University of Health and Welfare. Aged 18 to 30 years. Both sexes are eligible. Not restricted from exercising by a physician. Provided written informed consent after receiving an explanation of the study.

Key exclusion criteria

Individuals in poor physical condition (fever of 38 or higher, marked palpitations, shortness of breath, severe fatigue, or cold sweat). Individuals diagnosed at a health checkup with hypertension (resting blood pressure of 180/110 mmHg or higher), heart disease, or an infectious disease. Individuals with a history of cardiovascular disease, an orthopedic or neurological disorder requiring exercise restriction, or a serious medical condition currently under treatment, or who have been advised by a physician to restrict exercise. Individuals with an allergy to milk, dairy products, or soy. Individuals with a history of kidney disease. Individuals who habitually take protein supplements. Individuals with color vision deficiency.

Target sample size

48


Research contact person

Name of lead principal investigator

1st name Genta
Middle name
Last name Ochi

Organization

Niigata University of Health and Welfare

Division name

Faculty of Health Sciences, Department of Health and Sports

Zip code

950-3198

Address

1398 Shimami-cho, Kita-ku, Niigata-City

TEL

025-257-4595

Email

ochi@nuhw.ac.jp


Public contact

Name of contact person

1st name Genta
Middle name
Last name Ochi

Organization

Niigata University of Health and Welfare

Division name

Faculty of Health Sciences, Department of Health and Sports

Zip code

950-3198

Address

1398 Shimami-cho, Kita-ku, Niigata-City

TEL

025-257-4595

Homepage URL


Email

ochi@nuhw.ac.jp


Sponsor or person

Institute

Niigata University of Health and Welfare

Institute

Department

Personal name



Funding Source

Organization

Niigata University of Health and Welfare

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Niigata University of Health and Welfare

Address

1398 Shimami-cho, Kita-ku, Niigata-City

Tel

025-257-4455

Email

rinri@nuhw.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 08 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 08 Month 21 Day

Date of IRB


Anticipated trial start date

2026 Year 09 Month 01 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 08 Month 21 Day

Last modified on

2026 Year 08 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071706